These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 24080011)

  • 1. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
    Kim YS; Sun JM; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2013 Aug; 81(2):231-5. PubMed ID: 23683535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image of the month. Rash in a patient treated with pemetrexed for relapsed non-small cell lung cancer.
    Declercq I; Lievens Y; Verbeken E; Vansteenkiste J
    J Thorac Oncol; 2008 Jun; 3(6):662-3. PubMed ID: 18520810
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
    Pujol JL; Paul S; Chouaki N; Peterson P; Moore P; Berry DA; Salzberg M
    J Thorac Oncol; 2007 May; 2(5):397-401. PubMed ID: 17473654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study.
    Ciuleanu T; Brodowicz T; Zielinski C; Kim JH; Krzakowski M; Laack E; Wu YL; Bover I; Begbie S; Tzekova V; Cucevic B; Pereira JR; Yang SH; Madhavan J; Sugarman KP; Peterson P; John WJ; Krejcy K; Belani CP
    Lancet; 2009 Oct; 374(9699):1432-40. PubMed ID: 19767093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancer.
    de Marinis F; Passaro A; Clarke S
    Lung Cancer; 2013 Dec; 82(3):511. PubMed ID: 24080011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].
    de Marinis F; Ricciardi S
    Tumori; 2008; 94(5):suppl 3-13. PubMed ID: 19112963
    [No Abstract]   [Full Text] [Related]  

  • 7. Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison.
    Qi WX; Tang LN; He AN; Shen Z; Lin F; Yao Y
    Curr Med Res Opin; 2012 Apr; 28(4):643-50. PubMed ID: 22414178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer.
    Crinò L; Foglietta J; Hamzaj A
    J Thorac Oncol; 2007 May; 2(5 Suppl):S24-6. PubMed ID: 17457226
    [No Abstract]   [Full Text] [Related]  

  • 9. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemetrexed: current development and future directions in thoracic cancers.
    Manegold C
    Suppl Tumori; 2002; 1(4):S11-2. PubMed ID: 12415805
    [No Abstract]   [Full Text] [Related]  

  • 11. Pemetrexed disodium for the treatment of NSCLC: an update.
    Hsu JY; Wakelee H
    Drugs Today (Barc); 2008 Sep; 44(9):669-78. PubMed ID: 19137122
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.